dronedarone vs ezetimibe/simvastatin
Side-by-side comparison of dronedarone and ezetimibe/simvastatin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
major Known Drug Interaction
Amiodarone, Dronedarone, Ranolazine, or Calcium Channel Blockers Clinical Impact: The risk of myopathy and rhabdomyolysis is increased by concomitant use of amiodarone, dronedarone, ranolazine, or calcium channel blockers with VYTORIN. Intervention: For patients taking verapamil, diltiazem, or dronedarone, do not exceed VYTORIN 10/10 mg daily.
Recommendation: Do not take more than 10/10 mg of VYTORIN daily while you are taking dronedarone.
Multaq
Vytorin
Multaq is a medicine that helps lower the risk of needing to stay in the hospital for atrial fibrillation (AFib). It is for people who have a history of AFib and are currently in normal heart rhythm.
Vytorin is a combination medicine that contains ezetimibe and simvastatin. It helps lower bad cholesterol (LDL-C) in your blood.
Multaq is used to lower the risk of hospitalization if you have atrial fibrillation (AFib). AFib is an irregular heartbeat. This medicine is for people who used to have AFib, but are now in a normal heart rhythm.
Vytorin is used along with a healthy diet to lower high LDL cholesterol. It is used in adults with primary hyperlipidemia and in adults and children 10 years and older with heterozygous familial hypercholesterolemia (HeFH). Vytorin can also be used with other cholesterol-lowering treatments for adults with homozygous familial hypercholesterolemia (HoFH). Simvastatin, one of the drugs in Vytorin, can also lower the risk of heart problems like heart attack and stroke in adults with heart disease, blood vessel disease, or diabetes.
Multaq is an antiarrhythmic drug. It works by changing the electrical signals in the heart. This helps to keep your heart in a normal rhythm and prevent AFib from returning.
Ezetimibe reduces the amount of cholesterol your body absorbs from food. Simvastatin belongs to a class of drugs called statins. Statins lower cholesterol by blocking a substance your body needs to make cholesterol.
- • Diarrhea
- • Nausea
- • Abdominal pain
- • Vomiting
- • Feeling weak or tired
- • Headache
- • Increased liver enzyme (ALT)
- • Muscle pain
- • Upper respiratory tract infection
- • Diarrhea
- Irregular heartbeat 1,418
- Shortness of breath 834
- Tiredness 614
- Diarrhea 477
- Nausea 471
- Feeling sick to your stomach 1,008
- Feeling tired 771
- Feeling lightheaded 731
- General pain 702
- Muscle pain 669
Multaq can increase the risk of death, stroke, and heart failure in patients with severe heart failure or permanent AFib. You should not take this medicine if you have severe heart failure that recently required hospitalization or if you have permanent AFib and will not be converted to a normal heart rhythm.
Vytorin can cause muscle problems, including myopathy and rhabdomyolysis. Tell your doctor right away if you have unexplained muscle pain, tenderness, or weakness, especially if you also have a fever or feel sick. Vytorin can also cause liver problems. Your doctor may do blood tests to check your liver before you start taking Vytorin and while you take it.
Multaq can harm an unborn baby. If you are a woman who could become pregnant, use effective birth control while taking Multaq. Do not breastfeed while taking Multaq and for 5 days after your last dose.
Do not take Vytorin if you are pregnant. It can harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed, as it is not recommended during treatment with Vytorin.
Also Compare, Nearby Drugs
Compare dronedarone with
How to Read This dronedarone vs ezetimibe/simvastatin Comparison
dronedarone is classified in the Class III Antiarrhythmic drug class, while ezetimibe/simvastatin sits within the Cholesterol Absorption Inhibitor / Statin Combination class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, dronedarone has 3,814 submissions while ezetimibe/simvastatin has 3,881. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known major interaction flagged in FDA labeling, attributed to dronedarone interferes with how your body breaks down simvastatin, leading to higher drug levels and a greater risk of muscle damage.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between dronedarone and ezetimibe/simvastatin - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.